Literature DB >> 7550282

Melatonin receptors couple through a cholera toxin-sensitive mechanism to inhibit cyclic AMP in the ovine pituitary.

P J Morgan1, P Barrett, D Hazlerigg, G Milligan, W Lawson, A MacLean, G Davidson.   

Abstract

The nature of melatonin receptor-G-protein coupling in ovine pars tuberalis (PT) cells of the pituitary was addressed using cholera (CTX) and pertussis (PTX) toxins. ADP-ribosylation of ovine PT membrane proteins using 32P-NAD in the presence of CTX radiolabelled several substrates including 44, 51, and 60 kD proteins. Each were clearly distinct from the 40 kD substrate radiolabelled in the presence of PTX. Acute incubation of PT membranes with either toxin reduced the number of high affinity binding sites for 125I-MEL, although the magnitude of the inhibition was much greater for CTX (56%) than for PTX (20%). A CTX-sensitive component also mediates the inhibition of forskolin-stimulated cyclic AMP accumulation as pre-treatment of PT cells with CTX (5 micrograms/ml) for 16 h blocked this response. Gs alpha is a major substrate for ADP-ribosylation by CTX, and 16 h pre-treatment of PT cells with CTX (5 micrograms/ml) caused a down-regulation of Gs alpha. Northern analysis showed only one major transcript of Gs alpha of about 2 kb, which would encompass all of the known splice variants of the Gs gene. Screening of a cDNA library from ovine PT for Gs-related genes and sequencing of clones, combined with RT-PCR of PT mRNA, revealed no novel products. On this basis it is concluded that the CTX substrate is unlikely to be a novel splice variant or related gene product of the Gs class of G-protein.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7550282     DOI: 10.1111/j.1365-2826.1995.tb00770.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  4 in total

1.  Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice.

Authors:  Marta Zielińska; Agata Jarmuż; Maciej Sałaga; Radzisław Kordek; Moshe Laudon; Martin Storr; Jakub Fichna
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-02-22       Impact factor: 3.000

2.  Pharmacological characterization of human recombinant melatonin mt(1) and MT(2) receptors.

Authors:  C Browning; I Beresford; N Fraser; H Giles
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

3.  Melatonin.

Authors:  Paul Pévet
Journal:  Dialogues Clin Neurosci       Date:  2002-03       Impact factor: 5.986

4.  Establishment of TSH β real-time monitoring system in mammalian photoperiodism.

Authors:  Kaori Tsujino; Ryohei Narumi; Koh-hei Masumoto; Etsuo A Susaki; Yuta Shinohara; Takaya Abe; Masayuki Iigo; Atsushi Wada; Mamoru Nagano; Yasufumi Shigeyoshi; Hiroki R Ueda
Journal:  Genes Cells       Date:  2013-06-12       Impact factor: 1.891

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.